PRIM.JK Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: July 30, 2024
Report Source: 2024 1st Quarter Report
Royal Prima Tbk PT. Stock Analysis PRIM.JK
PT Royal Prima Tbk engages in the provision of healthcare and hospital services. The company is headquartered in Jakarta Barat, Dki Jakarta and currently employs 752 full-time employees. The company went IPO on 2018-05-15. The firm provides hospital services, clinics, polyclinics, and related business activities. Its segments are RSU Royal Prima, RS Royal Prima Jambi, and Rumah Sakit Marelan. The general health services include Emergency, Outpatient, Inpatient, Radiology, Medical Rehab, Pharmacy, and Micturating Cysto-Urethrogram (MCU). The specialized health services include General Surgery, Internist, Voluntary Counseling and Testing (VCT), Intensive Care Unit (ICU), Cardiology, Urology, Pediatric care, Endoscopy, and others. Other services include Acupuncture, Anesthesia, Beauty & Wellness, Dermatology, Dental and Mouth, Endocrine, Digestive, Vascular, Neurology, Ear Nose Throat (ENT), Nutrient Consultancy, Oncology, Plastic Surgery, Pediatric Surgery, Neurosurgery, Ophthalmology, Psychology, Orthopedic, and others. The firm operates through Royal Prima Medan, Royal Prima Marelan, and Royal Prima Jambi hospitals.
Read More Royal Prima Tbk PT (PRIM.JK) Chart
Key Statistics of Royal Prima Tbk PT (PRIM.JK)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
Rp84.00Volume
6.91MP/E Ratio (TTM)
-52 Week Range
Market Cap
281.52BAvg. Volume
20.99MDividend Yield
-Financial Metrics & Statements of Royal Prima Tbk PT (PRIM.JK)
FAQ's for Royal Prima Tbk PT (PRIM.JK)
- According to Musaffa’s Shariah screening methodology, Royal Prima Tbk PT (PRIM.JK) is currently classified as HALAL as of July 2024. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.